Nevus of Ota Treatment: Q-Switched Laser Sessions and Intervals

If you have a bluish or slate gray patch around the eye or on the cheek that keeps showing through no matter how many layers of concealer and foundation you apply, there is a good chance you are dealing with nevus of Ota. Unlike melasma or ordinary spots, the pigment here is not sitting on the surface, so piling on makeup does not hide it, no matter how thick the layer.

Nevus of Ota happens because the pigment producing cells never made it to where they were supposed to go, and instead settled deep in the skin from the very beginning. That is why makeup cannot cover it, and why treatment requires a laser that can reach that depth, delivered in 6 to 10 sessions spaced 6 to 8 weeks apart. Let's go through why the condition is built this way.

What causes a nevus of Ota?

Melanocytes, the cells that produce pigment, form in a tissue called the neural crest during fetal development and then migrate outward to the epidermis, the skin's surface layer. Once that migration is complete, they settle into the deepest layer of the epidermis, where they handle skin color and UV defense.

The problem is that this migration does not always go perfectly. In nevus of Ota, some melanocytes never finish the journey to the epidermis. They stop partway, in the dermis, the thick layer that sits underneath and supports the epidermis. If the epidermis is a thin surface membrane, think of the dermis as the thick wall holding it up from below.

Melanocytes that stall out in the dermis keep producing pigment right where they are. That is the fundamental difference from melasma or freckles, where the pigment sits in the epidermis. The condition tends to show up around the eyes, cheeks, and forehead, and this is thought to be related to the nerve distribution in that area.

Why doesn't makeup cover a nevus of Ota?

Concealer and foundation work by laying an opaque color over the surface of the skin to mask whatever color sits underneath. That works reasonably well for melasma or surface spots, because the pigment sits close to the surface.

But the pigment in nevus of Ota lives in the dermis, well below the epidermis. A layer of makeup is barely a millimeter thick, nowhere near enough to fully block a color showing through from several millimeters down. On top of that, the light scattering deep in the dermis produces a distinctive bluish or slate gray tone, and that tone is genuinely hard to match with a concealer built around brown undertones.

So no matter how thickly you apply it, the color underneath is never fully hidden, and it shows through differently depending on the angle and the lighting. Makeup is a solution for a surface problem. It is not a real answer for pigment sitting deep in the dermis.

Can toning and IPL treat it?

Standard laser toning or IPL (a broad spectrum light treatment) tends to concentrate its energy near the epidermis, which makes it effective for surface level melasma or pigment lesions. But the pigment in nevus of Ota sits much deeper, in the dermis, so these shallower treatments simply don't deliver enough energy down to where the pigment cells actually are.

Light behaves in a fairly predictable way here: the longer the wavelength, the deeper it penetrates into the skin. Shorter wavelengths get absorbed or scattered near the surface and never make it far, while longer wavelengths can punch through all the way into the dermis. That is why treating something as deeply seated as nevus of Ota requires choosing a laser with a long wavelength from the start.

This is the reason the Q-switched Nd:YAG laser has become the standard for treating nevus of Ota. At a wavelength of 1064nm, it is specifically designed to reach further down than most other lasers on the market.

How does a Q-switched laser remove pigment?

The defining feature of a Q-switched laser is that it fires light in extremely short bursts, measured in nanoseconds. A nanosecond is one billionth of a second, so think of it as concentrating a very strong burst of energy onto a single point in an instant.

When light this short and this intense hits a pigment granule, it causes a sudden expansion inside the particle that shatters it into fragments, similar to bringing a hammer down on a small stone and cracking it apart. Because the burst is over before the heat has time to spread to the surrounding tissue, the pigment breaks apart selectively while the damage to nearby skin stays relatively minimal.

The shattered pigment fragments don't just sit there afterward. Macrophages, the cells that act as the body's cleanup crew, arrive to engulf the fragments and gradually carry them out through the lymphatic system. That cleanup process takes time, which is why the color does not disappear right after treatment, but instead fades gradually over 4 to 6 weeks.

Why not treat it with one strong blast?

It's tempting to think that firing a stronger dose of energy in one go would clear the pigment faster. In practice, that is not how it works. The melanocytes sitting in the dermis are numerous and deeply positioned, so breaking down all of that pigment in a single session would require an extremely high energy level.

Pushing the energy that high doesn't just damage the pigment, it damages the healthy skin tissue around it too. That raises the risk of burns, scarring, or post inflammatory hyperpigmentation, where the pigment actually darkens instead of fading. Macrophages also have a limit to how fast they can process the broken down fragments, so producing too much debris in one sitting means the next round of treatment lands before the cleanup is finished, and the skin simply accumulates strain.

That is why treatment is delivered at a safer energy level, broken into stages, breaking down a modest amount of pigment each time and giving the body time to clear it before the next session. Fading gradually over 6 to 10 sessions is not an exception or a sign something went wrong. It's simply how this treatment is designed to work.

What determines how many sessions you need?

The number of sessions needed varies from person to person, shaped by a combination of factors:

• Depth and density of the pigment: the deeper and darker the pigment, the more limited the amount that can be broken down per session, which can push the total past 10 sessions to reach the desired result.
• How widely the lesion has spread: a larger area limits how much surface and energy can be covered in a single session, so treating the whole area evenly takes more rounds.
• Skin tone and age: darker skin tones and older patients are more prone to side effects like pigmentation at higher energy levels, so many practitioners lower the output and add sessions instead, favoring a safer, slower approach.

The interval between sessions is usually set at 6 to 8 weeks, which accounts for the macrophage cleanup time described earlier as well as the skin's own recovery window. Scheduling sessions too close together means new irritation lands before the cleanup is done, which can actually slow recovery down.

Precautions between treatments

The treated area is temporarily more sensitive, and UV exposure during this window can re-stimulate the pigment and make it darker rather than lighter. That is why sun protection matters more than usual, both during the treatment period and while the skin is recovering.

It's also common for the pigment to look temporarily more visible or for the area to redden and swell right after a session. This is generally considered a normal part of the pigment breaking down and being cleared out. Rather than pushing to schedule the next session earlier during this window, sticking to the planned interval and giving the skin time to recover tends to lead to a smoother course of treatment.

In the end, nevus of Ota differs from other pigment conditions precisely because of where the pigment sits, which is why neither makeup nor shallow treatments offer a real fix. Choosing a laser wavelength that can reach the dermis, and pacing sessions to what the skin can safely handle, remains the most realistic approach available.

References

Korean Dermatological Association, Ministry of Food and Drug Safety (MFDS), American Academy of Dermatology (AAD), and U.S. Food and Drug Administration (FDA).